cdrjournal's profile picture. Impact Factor 2024: 5.2 - Q1 (ONCOLOGY); CiteScore 2024: 8.3 - Q1 Pharmacology(medical). Indexed in PubMed Central(PMC), ESCI and Scopus #Cancer #DrugResistance

Cancer Drug Resistance

@cdrjournal

Impact Factor 2024: 5.2 - Q1 (ONCOLOGY); CiteScore 2024: 8.3 - Q1 Pharmacology(medical). Indexed in PubMed Central(PMC), ESCI and Scopus #Cancer #DrugResistance

مثبتة

🎉 CDR Impact Factor hits 5.2! Now ranked Q1 in Oncology (64/326) ⬆️ Up 13% from last year (4.6) Proud to be the only journal focused on cancer drug resistance. Huge thanks to our contributors and our amazing Editorial Board!👏 🔗More details here: oaepublish.com/news/cdr.1218

cdrjournal's tweet image. 🎉 CDR Impact Factor hits 5.2!

Now ranked Q1 in Oncology (64/326)

⬆️ Up 13% from last year (4.6)

Proud to be the only journal focused on cancer drug resistance.

Huge thanks to our contributors and our amazing Editorial Board!👏

🔗More details here: oaepublish.com/news/cdr.1218

🙌The new special topic is now accepting submissions! ✍️Key words: #UrologicalCancers; #DrugResistance 👉Guest Editors: @ Dr.William Cho; @DechaoF ; @UmberCheema; @UzoamakaOkoli2 ✉️Contacts: [email protected] 👋Welcome submissions!

cdrjournal's tweet image. 🙌The new special topic is now accepting submissions!

✍️Key words: #UrologicalCancers; #DrugResistance

👉Guest Editors: @ Dr.William Cho; @DechaoF ; @UmberCheema; @UzoamakaOkoli2   

✉️Contacts: Lori@cancerdrugresist.com

👋Welcome submissions!

🙌New publish in #Cancer #DrugResistance on 10 Oct. 👉Title: KLF5 promotes tumor proliferation and #oxaliplatin resistance via chromatin remodeling in KRAS-mutated #ColorectalCancer. 👀Read more: oaepublish.com/articles/cdr.2…

cdrjournal's tweet image. 🙌New publish in #Cancer #DrugResistance on 10 Oct.

👉Title: KLF5 promotes tumor proliferation and #oxaliplatin resistance via chromatin remodeling in KRAS-mutated #ColorectalCancer.

👀Read more: oaepublish.com/articles/cdr.2…

👉New publish in #Cancer #DrugResistance! 👏Title: #Cisplatin resistance in head and neck squamous cell carcinoma is linked to DNA damage response and cell cycle arrest #transcriptomics rather than poor drug uptake 👉Read: oaepublish.com/articles/cdr.2…

cdrjournal's tweet image. 👉New publish in #Cancer #DrugResistance!

👏Title: #Cisplatin resistance in head and neck squamous cell carcinoma is linked to DNA damage response and cell cycle arrest #transcriptomics rather than poor drug uptake

👉Read: oaepublish.com/articles/cdr.2…

👏New Special Issue in #Cancer #Drug #Resiatance! 🙌Topic: Deciphering Therapeutic Resistance in #UrologicalCancers: Bridging Clonal Evolution, Microenvironment, and Multi-Omics for Clinical Translation 👉Read more: oaepublish.com/specials/cdr.1…

cdrjournal's tweet image. 👏New Special Issue in #Cancer #Drug #Resiatance!

🙌Topic: Deciphering Therapeutic Resistance in #UrologicalCancers: Bridging Clonal Evolution, Microenvironment, and Multi-Omics for Clinical Translation

👉Read more: oaepublish.com/specials/cdr.1…

✨Good new: 52 Editorial Board Members of Cancer Drug Resistance Recognized in the "World's Top 2% Scientists 2025" List! 👏Prestigious Honor、 Global Impact、 Reinforcing the Journal's Influence in the Field! 👉Read more: oaepublish.com/news/cdr.1348

cdrjournal's tweet image. ✨Good new: 52 Editorial Board Members of Cancer Drug Resistance Recognized in the "World's Top 2% Scientists 2025" List!

👏Prestigious Honor、 Global Impact、 Reinforcing the Journal's Influence in the Field!

👉Read more: oaepublish.com/news/cdr.1348
cdrjournal's tweet image. ✨Good new: 52 Editorial Board Members of Cancer Drug Resistance Recognized in the "World's Top 2% Scientists 2025" List!

👏Prestigious Honor、 Global Impact、 Reinforcing the Journal's Influence in the Field!

👉Read more: oaepublish.com/news/cdr.1348
cdrjournal's tweet image. ✨Good new: 52 Editorial Board Members of Cancer Drug Resistance Recognized in the "World's Top 2% Scientists 2025" List!

👏Prestigious Honor、 Global Impact、 Reinforcing the Journal's Influence in the Field!

👉Read more: oaepublish.com/news/cdr.1348

👏New publish in #Cancer #DrugResistance! 👉Title: Molecular targeting of the deubiquitinase USP14 to circumvent cisplatin resistance in ovarian carcinoma and identification of novel inhibitors 👋Read more: oaepublish.com/articles/cdr.2…

cdrjournal's tweet image. 👏New publish in #Cancer #DrugResistance!

👉Title: Molecular targeting of the deubiquitinase USP14 to circumvent cisplatin resistance in ovarian carcinoma and identification of novel inhibitors

👋Read more: oaepublish.com/articles/cdr.2…

👏New publish in #Cancer #DrugResistance! 👉Title: Distinct adaptive strategies to cisplatin, vinblastine and gemcitabine in a panel of chemoresistant #bladdercancer cell lines 🙏Read more: oaepublish.com/articles/cdr.2…

cdrjournal's tweet image. 👏New publish in #Cancer #DrugResistance!

👉Title: Distinct adaptive strategies to cisplatin, vinblastine and gemcitabine in a panel of chemoresistant #bladdercancer cell lines

🙏Read more: oaepublish.com/articles/cdr.2…

🌟New Publication in #Cancer #DrugResistance! ☀️Title: #Immune #checkpoint #inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies 👉Read more: oaepublish.com/articles/cdr.2…

cdrjournal's tweet image. 🌟New Publication  in #Cancer #DrugResistance!

☀️Title: #Immune #checkpoint #inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies

👉Read more: oaepublish.com/articles/cdr.2…

📢 Newly Published Research in #Cancer #DrugResistance This study develops an integrated #PrognosticModel combining #TRAG signature, #TILs, and clinical features to guide personalized adjuvant #therapy. Read and download for free: f.oaes.cc/xmlpdf/publish…

cdrjournal's tweet image. 📢 Newly Published Research in #Cancer #DrugResistance

This study develops an integrated #PrognosticModel combining #TRAG signature, #TILs, and clinical features to guide personalized adjuvant #therapy.

Read and download for free: f.oaes.cc/xmlpdf/publish…

📢Newly Published Review in #Cancer #DrugResistance Can nanomedicine overcome hypoxia-driven immunotherapy resistance? The aim of this review: to bridge mechanistic insights with nanotechnology-enabled therapeutic solutions Read and download for free: f.oaes.cc/xmlpdf/publish…

cdrjournal's tweet image. 📢Newly Published Review in #Cancer #DrugResistance

Can nanomedicine overcome hypoxia-driven immunotherapy resistance? 

The aim of this review: to bridge mechanistic insights with nanotechnology-enabled therapeutic solutions

Read and download for free: f.oaes.cc/xmlpdf/publish…

📢 Newly Published Research How does #Cryptotanshinone selectively induce #CellDeath in #pancreatic #cancer? Explore the latest research for novel therapeutic insights! 📖Read and download for free: f.oaes.cc/xmlpdf/publish…

cdrjournal's tweet image. 📢 Newly Published Research

How does #Cryptotanshinone selectively induce #CellDeath in #pancreatic #cancer? 

Explore the latest research for novel therapeutic insights!

📖Read and download for free: f.oaes.cc/xmlpdf/publish…

🌟New publish in #Cancer #DrugResistance! ☀️Title: Resistance signatures manifested in early drug response across cancer types and species ✉️Read more: oaepublish.com/articles/cdr.2…

cdrjournal's tweet image. 🌟New publish in #Cancer #DrugResistance!

☀️Title: Resistance signatures manifested in early drug response across cancer types and species

✉️Read more: oaepublish.com/articles/cdr.2…

👉New publish in #Cancer #DrugResistance about #PancreaticCancer! 👏Title: Cryptotanshinone differentially induces cell death in ATP6V0D1-deficient pancreatic cancer cells 👐Read more: oaepublish.com/articles/cdr.2…

cdrjournal's tweet image. 👉New publish in #Cancer #DrugResistance about #PancreaticCancer!

👏Title: Cryptotanshinone differentially induces cell death in ATP6V0D1-deficient pancreatic cancer cells

👐Read more: oaepublish.com/articles/cdr.2…

🙌New publish on 2 Sep. in #Cancer #DrugResistance! 🔦Keywords: #Immunotherapy resistance, HIF-1α, tumor-associated macrophages, T cell exhaustion, immune evasion, vascular normalization, #nanomedicine 👉Read more: oaepublish.com/articles/cdr.2…

cdrjournal's tweet image. 🙌New publish on 2 Sep. in #Cancer #DrugResistance!

🔦Keywords:
#Immunotherapy resistance, HIF-1α, tumor-associated macrophages, T cell exhaustion, immune evasion, vascular normalization, #nanomedicine

👉Read more: oaepublish.com/articles/cdr.2…

📢 Newly Published Review in #Cancer #DrugResistance How can we overcome #ALK-targeted #therapy resistance in #LungCancer? 📖 Read for free: oaepublish.com/articles/cdr.2… 🔗Download PDF: f.oaes.cc/xmlpdf/publish…

cdrjournal's tweet image. 📢 Newly Published Review in #Cancer #DrugResistance
 
How can we overcome #ALK-targeted #therapy resistance in #LungCancer?

📖 Read for free: oaepublish.com/articles/cdr.2…
🔗Download PDF: f.oaes.cc/xmlpdf/publish…

🚀 Cancer Drug Resistance (CDR) – 2025 Second Round of Early-Career Editorial Board(ECEB) Recruitment! Join our ECEB & advance #Cancer #DrugResistance research! ✅ IF 5.2 | CiteScore 8.3 | Q1 Journal 📌 Apply now: docs.google.com/forms/d/e/1FAI… 🔍 Details: oaepublish.com/news/cdr.1292

cdrjournal's tweet image. 🚀 Cancer Drug Resistance (CDR) – 2025 Second Round of Early-Career Editorial Board(ECEB) Recruitment!

Join our ECEB & advance #Cancer #DrugResistance research!

✅ IF 5.2 | CiteScore 8.3 | Q1 Journal

📌 Apply now: docs.google.com/forms/d/e/1FAI…
🔍 Details: oaepublish.com/news/cdr.1292

🎉 Celebrate #OAE ’s 10th #Anniversary with #Cancer #DrugResistance – Enjoy a $400 #APC #Discount! 📅 Sep 1–Dec 31, 2025 (UTC) 💰 $400 off APC: $2,800 → $2,400 📄 All submissions eligible 📢Submit your research now! 🔗 Read the full announcement: oaepublish.com/news/cdr.1291

cdrjournal's tweet image. 🎉 Celebrate #OAE ’s 10th #Anniversary with #Cancer #DrugResistance  – Enjoy a $400 #APC #Discount!

📅 Sep 1–Dec 31, 2025 (UTC)
💰 $400 off APC: $2,800 → $2,400
📄 All submissions eligible

📢Submit your research now!

🔗 Read the full announcement: oaepublish.com/news/cdr.1291

⁉️How do #ROS1 mutations shape the #immune landscape and drive #resistance to #immunotherapy in #HeadAndNeckCancer? 👉Discover this impactful research published in #Cancer #DrugResistance Read and download for free: f.oaes.cc/xmlpdf/publish…

cdrjournal's tweet image. ⁉️How do #ROS1 mutations shape the #immune landscape and drive #resistance to #immunotherapy in #HeadAndNeckCancer?

👉Discover this impactful research published in #Cancer #DrugResistance

Read and download for free: f.oaes.cc/xmlpdf/publish…

🔦A publish about natural #sesquiterpenelactones in #Cancer #DrugResistance. 👉Title: Research advances in natural sesquiterpene lactones: overcoming cancer drug resistance through modulation of key signaling pathways 🙌Read more: oaepublish.com/articles/cdr.2…

cdrjournal's tweet image. 🔦A publish about natural #sesquiterpenelactones in #Cancer #DrugResistance.

👉Title: Research advances in natural sesquiterpene lactones: overcoming cancer drug resistance through modulation of key signaling pathways

🙌Read more: oaepublish.com/articles/cdr.2…

Loading...

Something went wrong.


Something went wrong.